Rockwell Medical Inc (RMTI)
1.50
+0.05
(+3.45%)
USD |
NASDAQ |
Apr 22, 16:00
1.52
+0.02
(+1.33%)
After-Hours: 20:00
Rockwell Medical Shareholders Equity (Quarterly): 21.29M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 21.29M |
September 30, 2023 | 21.52M |
June 30, 2023 | 9.528M |
March 31, 2023 | 12.54M |
December 31, 2022 | 14.11M |
September 30, 2022 | 16.14M |
June 30, 2022 | 20.14M |
March 31, 2022 | -4.807M |
December 31, 2021 | 2.535M |
September 30, 2021 | 11.09M |
June 30, 2021 | 18.20M |
March 31, 2021 | 26.18M |
December 31, 2020 | 34.17M |
September 30, 2020 | 42.08M |
June 30, 2020 | 16.21M |
March 31, 2020 | 21.77M |
December 31, 2019 | 20.32M |
September 30, 2019 | 23.70M |
June 30, 2019 | 29.59M |
March 31, 2019 | 20.16M |
December 31, 2018 | 27.28M |
September 30, 2018 | 12.67M |
June 30, 2018 | 16.89M |
March 31, 2018 | 27.37M |
December 31, 2017 | 32.91M |
Date | Value |
---|---|
September 30, 2017 | 40.79M |
June 30, 2017 | 43.85M |
March 31, 2017 | 50.61M |
December 31, 2016 | 52.96M |
September 30, 2016 | 55.76M |
June 30, 2016 | 57.63M |
March 31, 2016 | 60.21M |
December 31, 2015 | 62.32M |
September 30, 2015 | 64.43M |
June 30, 2015 | 65.99M |
March 31, 2015 | 67.82M |
December 31, 2014 | 68.70M |
September 30, 2014 | -5.460M |
June 30, 2014 | -3.914M |
March 31, 2014 | -3.527M |
December 31, 2013 | 0.5955M |
September 30, 2013 | 6.101M |
June 30, 2013 | 17.24M |
March 31, 2013 | -10.51M |
December 31, 2012 | -9.962M |
September 30, 2012 | 1.172M |
June 30, 2012 | 16.67M |
March 31, 2012 | 25.59M |
December 31, 2011 | 18.24M |
September 30, 2011 | 24.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.807M
Minimum
Mar 2022
42.08M
Maximum
Sep 2020
18.75M
Average
20.14M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | 0.607M |
Oragenics Inc | 3.168M |
Alpine Immune Sciences Inc | 327.94M |
Corvus Pharmaceuticals Inc | 38.68M |
MAIA Biotechnology Inc | 0.4775M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 52.17M |
Total Liabilities (Quarterly) | 30.88M |
Debt to Equity Ratio | 0.401 |
Current Ratio | 1.729 |
Net Debt Paydown Yield | 2.38% |